Gold Artemis Gold pours first gold and silver at Blackwater mine in BC The mine will produce 500,000 oz of gold equivalent annually for the first 10 years Joseph MortonJanuary 30, 2025
Psychedelics Optimi Health produces largest-ever batch of MDMA capsules The MDMA, psilocybin and functional mushroom producer also just scooped more funding Rowan DunneJanuary 29, 2025
High Performance Computing D-Wave Quantum’s new program gives enterprise access to quantum optimization tools The program has the potential to enable organizations to address critical problems with quantum technologies Joseph MortonJanuary 29, 2025
Alternative Energy China tightens grip around critical minerals market: new report Chinese financial institutions issued nearly USD$57 billion in loans to 19 low- and middle-income countries Joseph MortonJanuary 29, 2025
Gold Nevada Gold Mines and Nevada Department of Education team up on K-12 education In July 2020, the partnership made the K-12 learning platform free for all Nevada educators and students Joseph MortonJanuary 28, 2025
AI and Autonomy Median Technologies and European Investment Bank agrees to €37.5M loan The tech leverages machine learning to analyze imaging data generated by low-dose computed tomography Joseph MortonJanuary 28, 2025
Psychedelics Edmonton’s new psychedelic therapy clinic helps residents soothe the winter blues It offers ketamine, psilocybin, and MDMA therapy sessions Rowan DunneJanuary 27, 2025
Health & Wellness Akero Therapeutics nearly doubles stock price on positive clinical studies MASH is a more severe form of metabolic dysfunction-associated steatotic liver disease formerly known as non-alcoholic fatty liver disease Joseph MortonJanuary 27, 2025
Gold Discovery Silver picks up Newmont Corporation’s Porcupine Operations in Ontario for $425M Newmont spent the majority of 2024 sourcing and executing a series of strategic divestments Joseph MortonJanuary 27, 2025
Psychedelics MindBio Therapeutics uses AI speech analysis to see if you’ve taken its LSD drug The biopharma operator's lead drug candidate, MB22001, was created for microdosing Rowan DunneJanuary 24, 2025